CCSVI Latest News - Oct 2011 - Hubbard Foundation

[Guest guest]

thought this maybe of interest

 The Breakthrough Treatment for MS | View it in your browser.

Dr Tom Gilhooly has been invited to be a member of the Hubbard Foundation

Scientific Board which meets annually in San Diego. This board will help the

Foundation to direct future research in relation to its work on fMRI, CCSVI and

MS. His previous membership of UK and ish Government committees on

Addiction will be useful in making a significant contribution to this

prestigious scientific board. The Hubbard Foundation are particularly interested

in the nutritional aspects of Dr Gilhooly's work in the context of MS to enhance

the holistic approach to the disease.

 

Dr Gilhoolly commented

' " " It is a great honour to be invited onto the Scientific Board of the Hubbard

Foundation. Hubbard's presentation at the First Conference of the

International Society of Neurovascular Disease in Bologna was one of the most

memorable. His description of how CCSVI compliments the immune model of MS gives

a clear way forward for those involved in MS management. Functional MRI could be

a key objective method of assessing patient before and after angioplasty. Having

such close links with an internationally respected organisation will help with

the advancement of CCSVI treatment in the UK. "

 

The Hubbard Foundation was originally founded in 2007 to study the physiological

mechanisms of cognition in the brain using functional magnetic resonance

imaging, fMRI.  fMRI measures the blood flow within the brain itself and is

used worldwide to study the live brain.  When Hubbard MD, neurologist and

founder of the Hubbard Foundation, and his wife Arlene Hubbard, an Occupational

Therapist by training with a masters degree in counselling, learned their son

had Multiple Sclerosis (MS), they decided to use the foundation and fMRI to

investigate Multiple Sclerosis in order to find prevention, treatment and

ultimately a cure for this disease.

 

Multiple Sclerosis (MS) is a chronic disease of the brain and spinal cord,

causing physical and cognitive ailments.  Most treatments address the body’s

immune system, but new research findings suggest the focus should shift to the

vascular system, in particular the veins of the brain and spinal cord.  fMRI

can be used to study these problems. In 2010, the Hubbard’s began using fMRI

to study how to treat MS for the benefit of their son and people with MS

battling this disease across the globe.

 

The mission of the Hubbard Foundation is to research the vascular component of

neurological disorders, like Chronic Cerebrospinal Venous Insufficiency (CCSVI)

in Multiple Sclerosis, using functional MRI (fMRI) as well MRV,

flow-quantification, perfusion and other measures. Two papers on this topic are

expected to be published later this year; both were submitted to two

peer-reviewed Scientific journals respectively in early October 2011.  One

paper discusses abnormalities in the cerebral blood flow of MS patients, and a

return to normal following intervention.  The other will discuss clinical

outcomes of venous intervention in MS patients with occluded head, neck, or

chest veins. 

The Hubbard Foundation's national Registry is continuing to collect data from

over 20 sites across the US. Hubbard Foundation's research, as well as data from

other physicians and researchers worldwide, is presented at the annual

Conference in San Diego, educating not only people suffering from MS, but

physicians and researchers.

Our mailing address is:Unit 75, Arcade, Rutherglen, Glasgow. G73

2LSCopyright © 2011 Glasgow Health Solutions Ltd (T/A Essential Health

Clinic)All rights reserved.

Sent to peter.nicholls@... — why did I get this?

unsubscribe from this list | update subscription preferences

Glasgow Health Solutions Ltd · Unit 75 · Arcade · Rutherglen,

Glasgow FY6 8JX

[Guest guest]

It was sent to MSCured and many other groups - you received it as you are

a member of the groups it was sent to.

'What we do in life, echoes through eternity.'

MARCUS AURELIUS (121 - 180 A.D.)

To: LDN_Users ; lowdosenaltrexone ;

mscured ; MS_Community ; ms-diet ;

mswatchers

From: peter.nicholls@...

Date: Tue, 18 Oct 2011 16:32:38 +0100

Subject: CCSVI Latest News - Oct 2011 - Hubbard Foundation

thought this maybe of interest

The Breakthrough Treatment for MS | View it in your browser.

Dr Tom Gilhooly has been invited to be a member of the Hubbard Foundation

Scientific Board which meets annually in San Diego. This board will help the

Foundation to direct future research in relation to its work on fMRI, CCSVI and

MS. His previous membership of UK and ish Government committees on

Addiction will be useful in making a significant contribution to this

prestigious scientific board. The Hubbard Foundation are particularly interested

in the nutritional aspects of Dr Gilhooly's work in the context of MS to enhance

the holistic approach to the disease.

Dr Gilhoolly commented

' " " It is a great honour to be invited onto the Scientific Board of the Hubbard

Foundation. Hubbard's presentation at the First Conference of the

International Society of Neurovascular Disease in Bologna was one of the most

memorable. His description of how CCSVI compliments the immune model of MS gives

a clear way forward for those involved in MS management. Functional MRI could be

a key objective method of assessing patient before and after angioplasty. Having

such close links with an internationally respected organisation will help with

the advancement of CCSVI treatment in the UK. "

The Hubbard Foundation was originally founded in 2007 to study the physiological

mechanisms of cognition in the brain using functional magnetic resonance

imaging, fMRI. fMRI measures the blood flow within the brain itself and is used

worldwide to study the live brain. When Hubbard MD, neurologist and

founder of the Hubbard Foundation, and his wife Arlene Hubbard, an Occupational

Therapist by training with a masters degree in counselling, learned their son

had Multiple Sclerosis (MS), they decided to use the foundation and fMRI to

investigate Multiple Sclerosis in order to find prevention, treatment and

ultimately a cure for this disease.

Multiple Sclerosis (MS) is a chronic disease of the brain and spinal cord,

causing physical and cognitive ailments. Most treatments address the body’s

immune system, but new research findings suggest the focus should shift to the

vascular system, in particular the veins of the brain and spinal cord. fMRI can

be used to study these problems. In 2010, the Hubbard’s began using fMRI to

study how to treat MS for the benefit of their son and people with MS battling

this disease across the globe.

The mission of the Hubbard Foundation is to research the vascular component of

neurological disorders, like Chronic Cerebrospinal Venous Insufficiency (CCSVI)

in Multiple Sclerosis, using functional MRI (fMRI) as well MRV,

flow-quantification, perfusion and other measures. Two papers on this topic are

expected to be published later this year; both were submitted to two

peer-reviewed Scientific journals respectively in early October 2011. One paper

discusses abnormalities in the cerebral blood flow of MS patients, and a return

to normal following intervention. The other will discuss clinical outcomes of

venous intervention in MS patients with occluded head, neck, or chest veins.

The Hubbard Foundation's national Registry is continuing to collect data from

over 20 sites across the US. Hubbard Foundation's research, as well as data from

other physicians and researchers worldwide, is presented at the annual

Conference in San Diego, educating not only people suffering from MS, but

physicians and researchers.

Our mailing address is:Unit 75, Arcade, Rutherglen, Glasgow. G73

2LSCopyright © 2011 Glasgow Health Solutions Ltd (T/A Essential Health

Clinic)All rights reserved.

Sent to peter.nicholls@... — why did I get this?

unsubscribe from this list | update subscription preferences

Glasgow Health Solutions Ltd · Unit 75 · Arcade · Rutherglen, Glasgow

FY6 8JX